CN1130065A - 复方酮康唑外用制剂 - Google Patents

复方酮康唑外用制剂 Download PDF

Info

Publication number
CN1130065A
CN1130065A CN 95109576 CN95109576A CN1130065A CN 1130065 A CN1130065 A CN 1130065A CN 95109576 CN95109576 CN 95109576 CN 95109576 A CN95109576 A CN 95109576A CN 1130065 A CN1130065 A CN 1130065A
Authority
CN
China
Prior art keywords
external
ketoconazole
preparation
ointment
azone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95109576
Other languages
English (en)
Inventor
王安文
倪宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIANHONG NATURAL MEDICINE FACTORY
Original Assignee
DIANHONG NATURAL MEDICINE FACTORY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIANHONG NATURAL MEDICINE FACTORY filed Critical DIANHONG NATURAL MEDICINE FACTORY
Priority to CN 95109576 priority Critical patent/CN1130065A/zh
Publication of CN1130065A publication Critical patent/CN1130065A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种具有广谱抗菌、抗炎和抗瘙痒作用的治疗皮肤病的复方外用制剂。本外用制剂主要由以下成分组成(重量百分比):酮康唑0.5-2%、丙酸氯倍他索0.01-0.05%、抗生素0.1-2%、氮酮0.1-3%,余量为基质。本发明所述药物组方克服现有药物作用单一、疗效较低的缺点,是一种以抗真菌为主、适用于治疗多种皮肤病,使用方便、治愈率高、疗效快的外用制剂,特别适合农村、山区、野外作业及合并感染的皮肤病患者应用。

Description

复方酮康唑外用制剂
本发明涉及一种具有广谱抗菌、抗炎和抗瘙痒作用的治疗皮肤病的复方外用制剂。
皮肤真菌感染时常伴有炎症和细菌存在,单用抗真菌药往往效果不佳皮肤炎症不管是感染性或非感染性,单用激素消炎均易诱发真菌或细菌感染。
以往用于治疗上述病症的药剂多属单方组成,如抗真菌感染的外用制剂有克霉唑软膏、制霉菌素软膏、咪康唑软膏和酮康唑软膏等,抗细菌感染的外用制剂有新霉素软膏、红霉素软膏和磷霉素软膏等。激素抗炎外用制剂有氢化可的松软膏、醋酸曲安缩松软膏和丙酸氯倍他索软膏等。上述制剂由于疗效单一,对混合感染并发炎症的皮肤病疗效欠佳,或者会引起继发感染。
之后,出现以抗真菌、抗细菌药和激素抗炎药三类药物不同的组方制得的复方制剂。较为典型的有咪康唑、新霉素和醋酸曲安缩松复方(皮康霜)、制霉菌素、杆菌肽和曲安缩松复方(复方康纳乐霜)。其中制霉菌素主要抗念珠菌属,对皮肤癣菌感染疗效差,咪康唑具有广谱抗真菌活性,但在念珠菌和曲菌中已发现耐药菌株。
中国专利申请CN10867999A(申请号93103362.4)公开了“一种治疗常见皮肤病外用霜剂及制造方法”,其主要成份有薄荷脑,樟脑,水杨酸甲酯,冰片,麝香草酚和丙酸倍氯米松等,其特征在于含有氮酮,唑类衍生物的抗真菌药和基质,薄荷脑,樟脑,水杨酸甲酯,冰片,麝香草酚组成药油,其配比为药油5-25%、唑类衍生物的抗真菌药0.5-3%、丙酸倍氯米松0.005-0.05%、氮酮0.5-2%、基质加至100%,药油的配比为薄荷脑1-5%、麝香草酚、冰片、樟脑各0.1-6%,水杨酸甲酯1-7%。中国专利申请CN1090758(申请号93109140.3)公开了一种“氯新酮软膏”,其特征在于它包含有酮康唑、氯氟舒松、硫酸新霉素、氮酮和基质,其中基质包含有硬脂酸、单甘酯、白凡士林、吐温-80、甘油、蒸馏水,用于治疗皮炎和癣。
本发明的目的旨在提供一种用于治疗皮肤病的、具有广谱抗菌作用的复方酮康唑外用制剂。
本发明所述的复方酮康唑外用制剂主要由以下成分组成(重量百分比):酮康唑0.5-2%、丙酸氯倍他索0.01-0.05%、抗生素0.1-2%、氮酮0.1-3%,余量为基质。
本发明中,以酮康唑为抗真菌成分,酮康唑具有广谱强效抗真菌作用,抗菌谱比制霉菌素广,抗菌活性比咪康唑高,且未见耐药菌株出现;丙酸氯倍他索为高效安全的皮肤外用激素,它的加入有效地防止酮康唑外用后的局部副反应,明显减轻癣症的瘙痒症状,具有较强的抗炎作用,并能抑制过敏反应;抗生素为新霉素、氯霉素、利福平、红霉素、杆菌肽等;氮酮为透皮促进剂,氮酮的加入,可提高酮康唑的治疗效果,减少酮康唑、抗生素和丙酸氯倍他索的用量。本发明所述的外用制剂可制成软膏(油包水软膏、水包油软膏)、溶液剂、乳剂、气雾剂、凝胶剂和脂质体。软膏基质由油溶性部分和水溶性部分经乳化制得,油溶性部分20-80%(硬脂酸、十六醇/十八醇、单硬脂酸甘油酯、液状石蜡、凡士林、羊毛脂等),水溶性部分80-20%(甘油、丙二醇、聚乙二醇、水等),乳化剂1-5%(三乙醇胺,吐温-80、司盘、平平加等),也可采用其他各种常用软膏基质。溶液剂基质组成为:乙醇、甘油、聚乙二醇、丙二醇。除上述组分外,还可加入抗氧剂0.1-1%、防腐剂0.01-0.5%以及香精、色素等,也可采用其他溶液剂基质。
本发明所述药物组方克服现有药物作用单一、疗效较低的缺点,是一种以抗真菌为主、适用于治疗多种皮肤病、使用方便、治愈率高、疗效快的的外用制剂,特别适合农村、山区、野外作业及合并感染的皮肤病患者应用。本发明经试验证明可稳定二年以上,实验室试验表明具有明确的抗真菌、抗细菌和消炎止痒作用,各组分的作用不受其余组分的影响,常用剂量外用对实验大鼠的呼吸、循环和神经系统功能无明显影响,对豚鼠皮肤无刺激过敏作用,皮肤急性毒性和长期毒性均低微。临床研究治疗癣症60例,显效率100%,湿疹、皮炎65例,显效率89.23%,银屑病5例,显效率80%。
实施例1:复方酮康唑软膏
组成                配比(%)(w/w)
酮康唑              1.0
硫酸新霉素          0.5
丙酸氯倍他索        0.025
氮酮                1.0
吐温                3.0
对苯二酚            1.0
色素                适量
香精                适量
软膏基质            余量
将酮康唑、丙酸氯倍他索、氮酮加热溶于基质的油溶性部分,吐温-80溶于基质的水溶性部分,分别加热至75℃,混合乳化,搅拌冷却,在膏体50℃时加入硫酸新霉素和香精,搅拌冷却至室温,即得。
主要用于治疗浅部真菌病及湿疹、银屑病、皮炎等症。
实施例2:复方酮康唑洗剂(溶液剂)
组成                  配比(%)(w/w)
酮康唑                1.0
氯霉素                0.25
丙酸氯倍他索          0.5
氮酮                  0.5
甘油                  5.0
聚乙二醇              5.0
吐温                  2.0
椰子油基二乙醇酰胺    4%
羊毛脂                2%
防腐剂                0.5%
乙醇                  5.0
水                    余量
将酮康唑、丙酸氯倍他索、氯霉素和氮酮加入乙醇中,加温搅拌溶解,冷却。将其余组分溶解于水,加入上述溶液中搅拌均匀,即得。
作用与用途:本品对头皮真菌如发癣菌属、表皮癣菌属、小孢子菌属以及酵母菌如念珠菌属和糠秕马拉色氏霉菌具有强效抗菌活性,用于脂溢性皮炎和头皮糠疹引起的脱屑和瘙痒症等的治疗。

Claims (3)

1、一种复方酮康唑外用制剂,其特征在于主要由以下成分组成(重量百分比):酮康唑0.5—2%、丙酸氯倍他索0.01-0.05%、抗生素0.1-2%、氮酮0.1-3%,余量为基质。
2、按照权利要求1所述的外用制剂,其特征在于含有抗氧剂0.1-1%、
3、按照权利要求1所述的外用制剂,其特征在于含有防腐剂0.01-0.5%。
CN 95109576 1995-10-23 1995-10-23 复方酮康唑外用制剂 Pending CN1130065A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95109576 CN1130065A (zh) 1995-10-23 1995-10-23 复方酮康唑外用制剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95109576 CN1130065A (zh) 1995-10-23 1995-10-23 复方酮康唑外用制剂

Publications (1)

Publication Number Publication Date
CN1130065A true CN1130065A (zh) 1996-09-04

Family

ID=5077267

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95109576 Pending CN1130065A (zh) 1995-10-23 1995-10-23 复方酮康唑外用制剂

Country Status (1)

Country Link
CN (1) CN1130065A (zh)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102283850A (zh) * 2011-08-25 2011-12-21 西北农林科技大学 一种水包油型复方酮康唑纳米药物及其制备方法
CN103520206A (zh) * 2013-10-15 2014-01-22 陈嘉陵 一种治疗皮肤病的外用药物组合物及其制备方法
CN104523711A (zh) * 2014-11-27 2015-04-22 广东华润顺峰药业有限公司 酮康他索乳膏及其制备方法
CN105456182A (zh) * 2015-12-08 2016-04-06 浙江鼎泰药业有限公司 一种治疗真菌感染的外用乳膏及其生产方法
CN107441082A (zh) * 2017-07-20 2017-12-08 王昌华 治疗顽固癣的外用药及其制备方法
CN107693522A (zh) * 2017-09-30 2018-02-16 广东罗浮山国药股份有限公司 复方酮康唑在制备治疗过敏性皮炎的药物中的应用
CN108619159A (zh) * 2018-04-23 2018-10-09 蒋良亚 护肤品制剂、其制备方法及其应用

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102283850A (zh) * 2011-08-25 2011-12-21 西北农林科技大学 一种水包油型复方酮康唑纳米药物及其制备方法
CN103520206A (zh) * 2013-10-15 2014-01-22 陈嘉陵 一种治疗皮肤病的外用药物组合物及其制备方法
CN103520206B (zh) * 2013-10-15 2015-04-29 陈嘉陵 一种治疗皮肤病的外用药物组合物及其制备方法
CN104523711A (zh) * 2014-11-27 2015-04-22 广东华润顺峰药业有限公司 酮康他索乳膏及其制备方法
CN104523711B (zh) * 2014-11-27 2018-01-09 广东华润顺峰药业有限公司 酮康他索乳膏及其制备方法
CN105456182A (zh) * 2015-12-08 2016-04-06 浙江鼎泰药业有限公司 一种治疗真菌感染的外用乳膏及其生产方法
CN107441082A (zh) * 2017-07-20 2017-12-08 王昌华 治疗顽固癣的外用药及其制备方法
CN107693522A (zh) * 2017-09-30 2018-02-16 广东罗浮山国药股份有限公司 复方酮康唑在制备治疗过敏性皮炎的药物中的应用
CN108619159A (zh) * 2018-04-23 2018-10-09 蒋良亚 护肤品制剂、其制备方法及其应用

Similar Documents

Publication Publication Date Title
EP1051193B1 (en) Anhydrous topical skin preparation comprising ketoconazole
DE60315939T2 (de) Pharmazeutische zusammensetzung enthaltend ein androgen
CN1130065A (zh) 复方酮康唑外用制剂
WO2010119385A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
US20120035144A1 (en) Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it.
WO2010122475A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it
WO2010109423A1 (en) A medicinal antifungal and steroids cream comprising chitosan and a process to make it
MXPA05003805A (es) Composiciones farmaceuticas que comprenden una combinacion de calcitriol y propionato de clobetasol.
CN1038387C (zh) 一种治疗常见皮肤病外用霜剂及其制造方法
RU2736940C2 (ru) Комбинированная фармацевтическая композиция для наружного применения
WO2011101826A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, terbinafine and dexamethasone, and a process to make it
Thaker et al. Formulation and charaterization of antifungal drug microemulsion hydrogel for topical drug delivery
JPH09176014A (ja) 抗真菌性外用組成物
WO2012017381A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, beclomethasone dipropionate, clotrimazole and a process to make it
WO2012017372A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, clobetasol propionate, miconazole nitrate and a process to make it
WO2012023082A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - terbinafine hydrochloride, and a process to make it
WO2011101824A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole, dexamethasone, and a process to make it
WO2010122493A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it
EP1159956B1 (en) Anhydrous topical skin preparations
WO2011101831A2 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasone butyrate, and an antifungal agent -terbinafine hydrochloride and a process to make it
WO2010122476A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole and mometasone, and a process to make it
WO2010122494A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and mometasone, and a process to make it
CN118217228A (zh) 一种那氟沙星乳膏及其制备方法和应用
WO2011101829A2 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - betamethasone dipropionate and an antifungal agent - miconazole nitrate, and a process to make it
WO2012023079A1 (en) A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, fluticasone propionate, oxiconazole nitrate and a process to make it

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication